×
Developing novel therapies for the treatment of prostate cancer. EPI-7386 - a new approach to disrupting androgen receptor signaling pathway.
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
People also ask
Find the latest ESSA Pharma Inc. (EPIX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: relations | Show results with:relations
GARMIN INVESTOR NEWS ... Garmin Ltd. invites investors to listen to its first quarter 2024 earnings conference call on Wednesday, May 1, 2024 at 10:30 a.m. EDT.
Peter wasa member of the executive team and responsible for all financial operations, investor relations, lender relationships, mitigating key elements of ...
Investor Relations Intelligence. Featured Solutions. Nasdaq Boardvantage® · Board Evaluations · Nasdaq IR Insight® · Nasdaq Metrio · See All Solutions ->. About.
Information on acquisition, funding, investors, and executives for Epix. Use the PitchBook Platform to explore the full profile.
Missing: relations | Show results with:relations
... EPIX Pharmaceuticals, Inc. 161 First Street, Cambridge, Massachusetts, Attn: Investor Relations, tel: (617) 250-6000; e-mail: ahedison@epixpharma.com or ...
Rating (2,975)
ESSA Pharma Inc (EPIX) will release its next earnings report on May 6, 2024. In the last quarter ESSA Pharma Inc reported -$0.168 EPS in relation to -$0.14 ...